Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19370415rdf:typepubmed:Citationlld:pubmed
pubmed-article:19370415lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C0665341lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:19370415lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:19370415pubmed:issue2lld:pubmed
pubmed-article:19370415pubmed:dateCreated2010-3-16lld:pubmed
pubmed-article:19370415pubmed:abstractTextTo investigate a presumed crosstalk between estrogen receptor alpha (ERalpha) and the TGF-beta signaling pathway in breast cancer, we analyzed the TGF-beta-induced expression of the plasminogen activator inhibitor 1 (PAI-1) gene in ER-positive MCF-7 cells. After siRNA-mediated knock-down of endogenous ERalpha, the transcription level of PAI-1 was upregulated, pointing to an attenuation of TGF-beta signaling by the presence of ERalpha. We verified these findings by a vice versa approach using a primary ER-negative cell model transiently overexpressing either ERalpha or ERbeta. We found that ERalpha, but not ERbeta, led to a strong inhibition of the TGF-beta1 signal, monitored by TGF-beta reporter assays. This attenuation was completely independent of receptor stimulation by beta-estradiol (E2) or inhibition by the pure antagonist ICI 182.780 (ICI). Our results indicate a permanent repression of PAI-1 by ERalpha and suggest a ligand-independent crosstalk between ERalpha and TGF-beta signaling in breast cancer cells.lld:pubmed
pubmed-article:19370415pubmed:languageenglld:pubmed
pubmed-article:19370415pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19370415pubmed:citationSubsetIMlld:pubmed
pubmed-article:19370415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19370415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19370415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19370415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19370415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19370415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19370415pubmed:statusMEDLINElld:pubmed
pubmed-article:19370415pubmed:monthAprlld:pubmed
pubmed-article:19370415pubmed:issn1573-7217lld:pubmed
pubmed-article:19370415pubmed:authorpubmed-author:KnabbeCorneli...lld:pubmed
pubmed-article:19370415pubmed:authorpubmed-author:StopeMatthias...lld:pubmed
pubmed-article:19370415pubmed:authorpubmed-author:BuckMiriam...lld:pubmed
pubmed-article:19370415pubmed:authorpubmed-author:PoppSimone...lld:pubmed
pubmed-article:19370415pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19370415pubmed:volume120lld:pubmed
pubmed-article:19370415pubmed:ownerNLMlld:pubmed
pubmed-article:19370415pubmed:authorsCompleteYlld:pubmed
pubmed-article:19370415pubmed:pagination357-67lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:meshHeadingpubmed-meshheading:19370415...lld:pubmed
pubmed-article:19370415pubmed:year2010lld:pubmed
pubmed-article:19370415pubmed:articleTitleEstrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.lld:pubmed
pubmed-article:19370415pubmed:affiliationDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.lld:pubmed
pubmed-article:19370415pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19370415pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2099entrezgene:pubmedpubmed-article:19370415lld:entrezgene
entrez-gene:5054entrezgene:pubmedpubmed-article:19370415lld:entrezgene
entrez-gene:7040entrezgene:pubmedpubmed-article:19370415lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19370415lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19370415lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19370415lld:entrezgene